U.S. STOCKS ON THE MOVE-Take-Two, Virios Therapeutics, Netflix
Allakos stock offering priced at $5.02/shr; to raise $150 mln
Brief: Allakos Announces Pricing Of $150 Mln Underwritten Offering Of Common Stock
Brief: Allakos Announces Initiation Of Phase 2B Clinical Trial Of Subcutaneous Lirentelimab In Chronic Spontaneous Urticaria (CSU)
U.S. RESEARCH ROUNDUP- Booking Holdings, Carvana, Kroger
U.S. STOCKS ON THE MOVE-OFS Credit, Nike, Elevance Health
U.S. STOCKS ON THE MOVE-CytoSorbents, Tapestry, Wayfair
U.S. STOCKS ON THE MOVE-Mogu, Energy firms, Kroger
Allakos slumps on anti-inflammatory treatment's mixed trial results
Brief: Allakos Announces Topline Phase 3 Data From The Eodyssey Study In Patients With Eosinophilic Duodenitis
U.S. RESEARCH ROUNDUP- Carvana, McKesson, Nektar Therapeutics
Allakos Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP-Enovix, IRhythm Technologies, Paramount Global
Brief: Allakos Entered Into A Sales Agreement For Sale Of Up To $75 Mln Shares
Brief: Allakos Provides Business Update And Reports Q2 Results
Brief: Allakos Files For Offering Of Up To $250 Mln Shares Of Common Stock - SEC Filing
U.S. RESEARCH ROUNDUP- Dutch Bros, Valvoline, Walt Disney
Allakos Inc reports results for the quarter ended in March - Earnings Summary
Brief: Allakos Q1 Loss Per Share $3.60